Editorial: Computational Genomics and Molecular Medicine for Emerging COVID-19

The papers in this special section focus on computational genomics and molecular medicine for emerging COVID-19. In 2020, World Health Organization announced Coronavirus disease (COVID)-19 is a pandemic disease, which is devastated the socio-economic life around the world. The disease caused by the zoonotic single-strand RNA virus known as “SARS-CoV-2”. To overcome the pandemic, the diagnosis and therapeutics products needs to be developed in short term. Developing therapeutics for infectious diseases, especially viral diseases always a challenging task for the scientific community. However, the utility of high-performance computational resources, artificial intelligence, and machine-learning algorithms can make the process in an affordable way through the usage of genomics, proteomics, pharmacogenomics, and chemical data. Thus, the special section received potential research articles related to computational genomics, molecular medicine, and COVID-19 from reputed scientist around the world. Different articles were employed machine learning, molecular dynamics, computer aided drug design techniques, and emphasizing viral genomics, mutation, drug target, drug candidates, and patient data, were included in this special section.